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Abstract
Duchenne muscular dystrophy is an inherited muscle wasting disease with severe symptoms and onset in early
childhood. Duchenne muscular dystrophy is caused by loss-of-function mutations, most commonly deletions, within
the DMD gene. Characterizing the junction points of large genomic deletions facilitates a more detailed model of the
origins of these mutations and allows for a greater understanding of phenotypic variations associated with particular
genotypes, potentially providing insights into the deletion mechanism. Here, we report sequencing of breakpoint
junctions for seven patients with intragenic, whole-exon DMD deletions. Of the seven junction sequences identiﬁed,
we found one instance of a “clean” break, three instances of microhomology (2–5 bp) at the junction site, and three
complex rearrangements involving local sequences. Bioinformatics analysis of the upstream and downstream
breakpoint regions revealed a possible role of short inverted repeats in the initiation of some of these deletion events.
Introduction
Duchenne muscular dystrophy is an inherited neuro-
muscular disease arising from loss-of-function mutations in
the DMD gene. The primary symptom of Duchenne mus-
cular dystrophy is a progressive deterioration of all muscles
in the body apart from the extraocular muscles1. Mild to
moderate intellectual impairment is also observed in some
cases, and there is evidence of an inverse relationship
between the severity of cognitive effect and the age of
physical onset2. Intellectual impairment can be exacerbated
in cases where the causative genomic lesion extends into
nearby genes such as NROB1 (ref. 3) and GKD4.
While a diverse array of mutation types can give rise to
Duchenne muscular dystrophy or the symptomatically
milder Becker muscular dystrophy, the majority of the
pathological mutations of the DMD gene are deletions5,
many of which encompass one or more entire exons.
The clearest predictor of the phenotype that will result
from a large intragenic deletion is the set of exons lost. If
the loss of these exons disrupts the gene’s open reading
frame, the processed mRNA will either be translated into a
truncated protein or be degraded by nonsense mediated
decay before translation can be completed6. If, on the other
hand, the deletion preserves the reading frame, it is far more
likely that a functional protein isoform will be produced7,
though this cannot be guaranteed8. While the DMD gene
possesses a high degree of redundancy, especially in the
central rod domain, not all DMD exons are equally dis-
pensable9. An abridged dystrophin protein may retain much
of its structural function, but loss of exons encoding the
hinges10,11, actin-binding domain12, or dystroglycan-
binding domain13 of the gene will necessarily impact the
functions of those parts of the protein, leading to a phe-
notype distinct from that which may have arisen from a
similarly sized in-frame deletion elsewhere in the gene.
The phenotype produced by a DMD whole-exon dele-
tion is not predicted solely by the identities of the exons
lost. Some intronic DMD sequences serve important
regulatory roles both before14,15 and after mRNA spli-
cing16, and deletions that affect functional regions such as
these are likely to have negative consequences for the
patient’s phenotype—consequences that can vary greatly
even among patients with identical exon deletions16. In
some cases, the unique conjunction of intronic sequences
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caused by a deletion can trigger the inclusion of a dele-
terious pseudoexon in the predominant transcript17,18.
Given these factors and the role that intron secondary
structure plays in pre-mRNA splicing19, it is plausible that
the unique intronic span of a DMD deletion may also
affect how readily the nearby exons will respond to anti-
sense oligonucleotide-mediated exon-skipping therapy.
For these reasons, it is of great value to both the patient
and the researcher to fully map the intronic breakpoints
in DMD whole-exon deletion cases, particularly those that
manifest atypical phenotypes. Not only will this knowl-
edge empower the patient to better understand their own
disease, but comparison of symptoms between patients
with fully mapped whole-exon deletions may lead to the
discovery of new regulatory regions within the DMD
introns and provide some insight into how these
mutations occur.
In this study, successive rounds of PCR were used to
delimit and amplify the genomic breakpoint junctions of
seven Duchenne or Becker muscular dystrophy patients
with whole-exon deletions. To economize on primers, we
limited our study to deletions within the DMD deletion
mutation hotspot, deﬁned as spanning introns 44 to 55
(ref. 20). Bioinformatics web tools were then used to
search the sequence around the breakpoints for features
that may have contributed to each deletion event. Our
analysis indicated that these deletions probably originated
via multiple repair and recombination pathways.
Materials and methods
Selection of cell strains and DNA extraction
Seven patient myoblast or ﬁbroblast cell strains were
selected from our cell database (see Table 1). Each
of the donor patients had been diagnosed with a dele-
tion of at least one whole exon in the e45–e51 region of
the DMD gene based on sequencing of their mRNA
prior to the commencement of this study. We also
selected a human myoblast strain not known to carry
any disease-causing allele for use as a normal control.
The eight cell strains were resurrected and cultured,
and the DNA was extracted and puriﬁed using the
PureLink Genomic DNA Kit from Invitrogen (Ther-
moFisher, Melbourne).
PCR
PCRs were performed using AmpliTaq™ Gold DNA
Polymerase from Invitrogen (ThermoFisher, Melbourne).
Sets of up to seven primer pairs were designed at intervals
across each intron expected to bear a deletion breakpoint.
These primer sets were used to perform multiplex PCRs
of the target genomic DNAs, and the reaction products
were visualized on an agarose gel. The number of bands
obtained for each reaction indicated the approximate
extent of the deletion, and this information was used to
inform successively more focused rounds of primer design
and multiplex PCR. Once the breakpoints on either side
of each deletion had been sufﬁciently delimited, a ﬁnal
PCR across the junction generated an amplicon contain-
ing the junction sequence (see Table 2 for primer
sequences).
Sequencing
Junction amplicons were puriﬁed using Difﬁnity
RapidTips™ (Chiral Technologies, Tokyo, Japan) and
submitted to the Australian Genome Research Facility
(Perth) for Sanger sequencing.
Table 1 Details of the seven DMD exon deletion cell strains used in this study
Patient ID Exon deletion ORF preserved? Assigned phenotype Cell type Origin
d1 45–49 Yes Becker muscular dystrophy Myoblast Dubowitz Neuromuscular Centre, London,
United Kingdom
d2 45–47 Yes Becker muscular dystrophy Myoblast Dubowitz Neuromuscular Centre, London,
United Kingdom
d3 45–47 Yes Becker muscular dystrophy Myoblast Dubowitz Neuromuscular Centre, London,
United Kingdom
d4 45–50 No Duchenne muscular dystrophy Fibroblast The Children’s Hospital at Westmead, Sydney,
Australia
d5 46–51 No Duchenne muscular dystrophy Myoblast Hammersmith Hospital, London, United
Kingdom
d6 48–50 No Duchenne muscular dystrophy Myoblast Dubowitz Neuromuscular Centre, London,
United Kingdom
d7 51 No Duchenne muscular dystrophy Fibroblast Dystrophy Annihilation Research Trust
Centre, Bengaluru, India
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Bioinformatics
As per Verdin et al.21, we deﬁned the breakpoint regions
as the 150 bp surrounding each deletion breakpoint in the
reference sequence (UCSC Genome Browser assembly ID
hg38, Chromosome X). In cases of breakpoint junction
microhomology, the 3′ end of the homologous sequence
deﬁned the center of the upstream and downstream
sequence.
The web utility Non-B DB22 was used to search the
150 bp surrounding each breakpoint for non-B DNA
features (i.e., A-phased repeats, direct repeats and slipped
motifs, G-quadruplex forming repeats, inverted repeats
and cruciform motifs, mirror repeats and triplex motifs,
Z-DNA motifs, and short tandem repeats). Sequences
were entered in FASTA format, and the results were saved
as text ﬁles.
The “Repeating Elements” track of the UCSC Genome
Browser23 was used to search the breakpoint regions for
transposable elements and other repetitive sequences, and
screen captures were taken of any relevant features. The
gnomAD genome database24 was also searched for pre-
viously reported common polymorphisms at the junction
sites, which, if present, may have contributed to the
initiation of the observed mutation.
Results
Sequences of the deletion breakpoint regions for seven
DMD patient cell lines are shown in Fig. 1, formatted in
the style of Esposito et al.25. Microhomologies and other
sequence anomalies are indicated where they occur, as are
inverted repeats discovered in the corresponding regions
of the reference sequence (NG_012232.1(DMD_v001)).
Aside from the inverted repeats, no other non-B DNA
structures were detected.
The relative positions of each breakpoint within introns
44 to 51 of the DMD gene are shown in Fig. 2. The
deletion junctions of patients d1, d2, and d6 exhibited
microhomologies of 2, 5, and 4 bp, respectively. Patients
d3, d4, and d7 each had inserted tracts of sequence at
their deletion junctions. For patient d3, this inserted tract
consisted of a 13 bp copy of the intron sequence imme-
diately 3′ of the junction, followed by a 9 bp novel
sequence (22 bp total). Patient d7’s junction showed a
similar feature, though in this case, the inserted sequence
is only 5 bp and appears to be a partial copy of a local 9 bp
tract. A G > C substitution was also noted 9 bp 3′ of
patient d7’s junction, though this is a commonly reported
variant (rs6527115, dbSNP build 151—see ref. 26). The
deletion junction of patient d4 exhibited a 45 bp de novo
insertion that appeared to be composed of disordered and
partially nested copies of tracts of the surrounding
sequence. Patient d5’s deletion junction appeared to be a
“clean break”, with no microhomology or de novo
sequence insertions.
The “Repetitive Elements” track of the UCSC Genome
Browser found transposons and retrotransposons at 5 of
the 14 reference sequence breakpoint regions. Images of
these elements are shown in Fig. 3.
No previously reported common polymorphisms at the
junction sites were found in the gnomAD database.
Discussion
Patients d1, d2, and d6—junction microhomologies
Deletion breakpoint junction microhomologies, such as
those observed for patients d1, d2, and d6, are a feature
common to many deletion mutations. In their 2013 study,
Verdin et al.21 cataloged 22 microhomologies in the FOX2
genes of separate patients, ranging in size from 1 to 66 bp.
They found that microhomologies occurred at a much
higher rate than would be expected if the upstream and
downstream breakpoints were completely random (p=
2.28 × 10–8) and noted that the regions around the
breakpoints tend to be signiﬁcantly enriched with repe-
titive elements.
Patient d2’s deletion could be a product of
microhomology-mediated end joining (MMEJ), repairing
a double-stranded break in the DMD27. Other research
has implicated MMEJ in large deletions of other genes28,
Table 2 Sequences of primers used to amplify genomic deletion junctions (gene reference NG_012232.1(DMD_v001))
and corresponding amplicon regions
Patient ID Forward primer (5′-3′) Reverse primer (5′-3′) Amplicon
d1 CATATGGTTTCTGGCCTTAG TGCTGTGAACTACAAAGCAC 1,171,882–1,518,667
d2 GGAACAGTATTCTAGGCAGG CATCCCTCCCTTCTATGAAC 1,265,936–1,449,576
d3 CACAAGGGTGTTAAGAACTACC GATAGTTTCAATAATATGACCATG 1,329,623–1,453,916
d4 CACCTCTTCTCATCTAATTCC CGATCACAATCTTCTGTGAAG 1,366,876–1,552,860
d5 CTATGAACAGGTATAAACCTG CAGGACCAGCTTCTTGAACG 1,377,531–1,608,719
d6 GCCTATGGTAAGATTGGTTTC CCCTTGAGAAATATCTCCAAC 1,427,297–1,563,083
d7 CTCCTATTTCAGCAAGTATC GACCCTGGTAGGTACATCATG 1,548,853–1,584,826
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Fig. 1 Junction sequences for seven patients with DMD whole-exon deletions, aligned to the corresponding regions of the reference
sequence NG_012232.1(DMD_v001). Regions of microhomology are enclosed in boxes. Arrowheads indicate inferred breakpoint sites. New
nucleotides are in bold type. Nonconsecutive direct repeats are underlined, with dashed and thicker lines used where necessary to distinguish
complex repeat arrangements (d4). Left- and right-pointing arrows indicate the 5′ and 3′ spans, respectively, of short inverted repeats
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and the microhomology observed in this case (TTATC)
was within the 5–25 bp size range required for this repair
pathway.
The breakpoints of the deletions of patients d1 and d6
(Fig. 1) were too small to be attributed to MMEJ (2 and
4 bp, respectively). It is possible that they arose from
nonhomologous end joining (NHEJ), as use of this path-
way can be assisted by small microhomologies at the
breakpoints29 even though it does not strictly require
them. Microhomology-mediated break induced replica-
tion (MMBIR) is also a possibility, as this pathway does
not always create new sequences. However, this hypoth-
esis is less likely, as evidence from other mammals indi-
cates that MMBIR is responsible for substantially fewer
breakpoint junctions than NHEJ30.
Patients d3, d4, and d7—complex insertions at junctions
Patients d3, d4, and d7 all exhibited complex sequence
insertions at their breakpoint junctions. A likely expla-
nation for how these deletion junction sequences arose is
MMBIR. This repair pathway is known to cause complex
rearrangements of the DNA at the breakpoint junction,
including duplications, inversions, and deletions31.
MMBIR requires microhomologies at each breakpoint,
and these were not observed for patients d3, d4, or d7.
However, the microhomologies required for MMBIR need
only be 1–3 bp long, and in cases where complex non-
canonical junction sequences are created, such small
sequence features could easily be obscured.
Patient d5 deletion junction—clean break
The clean break observed at patient d5’s deletion junc-
tion indicates that this deletion probably arose via NHEJ25,
as this is the only repair or recombination pathway known
to be capable of producing clean break junctions.
The role of transposable elements in facilitating large
deletions
Transposable elements have been implicated as a cau-
sative factor in many large genomic deletions32,33, and it
has been proposed that homology between two transpo-
sable elements facilitates non-allelic homologous
recombination (NAHR)34. We detected a retrotransposon
L2a site at the 5′ breakpoint region of patient d2, as well as
transposons at both of patient d6’s breakpoints and both of
patient d7’s breakpoints (Fig. 3). However, a BLAST-N
analysis of each breakpoint pair for the deletions of
patients d3, d4, and d7 could not detect any signiﬁcant
homology, and thus it does not appear that these sequence
features contributed to the deletion events.
The role of non-B DNA in large deletions
Non-B DNA conformations may facilitate large geno-
mic deletions by interacting with local microhomologies
to errantly initiate the double-stranded break repair
mechanism35,36. Our analysis detected six inverted repeats
(size range 12–16 bp) across six of the deletion breakpoint
regions but did not ﬁnd any examples of the other
searched-for features.
Short inverted repeats have previously been implicated
in the occurrence of large genomic deletions37,38 and Lu
et al.39 found that inverted repeats as small as 7–30 bp are
positively associated with deletion breakpoint locations in
human cancers. While it is not possible to replicate Lu
et al.’s statistical analysis with a sample size of 14 break-
points from seven nonrandomly selected patient cell lines,
our ﬁndings are at least compatible with the hypothesis
that short inverted repeats play a role in the initiation of
some of the studied deletion events.
Conclusion
It has been suggested that large genomic deletion
breakpoints do not occur randomly, but instead arise as a
result of local features in the genome21. Indeed, there are
a number of ways that asymmetrical chromosomal rear-
rangements can occur, producing deletions in tandem
with other rearrangements, such as inversions or dupli-
cations40. Even with a sample size of just seven deletions
from a single gene, we have observed a surprising diversity
of junction phenomena and inferred a comparable
diversity of contributing genomic factors and repair
pathways. Developing a model that can incorporate all
these factors and predict where and how deletions occur
remains a daunting task—but it is a goal worth pursuing,
Fig. 2 Relative positions of DMD gene deletion breakpoints for seven patients. Patient IDs are indicated, as are the total sizes of the deletions
(excluding any de novo sequence inserted at the junction). Due to the large size of many of the introns in this region of the gene, intervening exons
are not visible at this scale
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Fig. 3 Repetitive elements detected within 150 bp deletion breakpoint regions of DMD exon deletion patients d2, d6, and d7. Vertical
dashes indicate the breakpoint location relative to the normal sequence. Darker shading on a repetitive element indicates a stronger match to that
element’s consensus sequence
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both for its outcomes for human knowledge and for better
informing genetic disease patients and their families.
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